March 4-5, 2019

Gulfstream Park

A first of its kind, two-day continuing education conference for regulatory and official racetrack veterinarians.

Presented by RMTC and NTRA Safety & Integrity Alliance

“Regulatory veterinarians hold a unique position in the protection of the health and welfare of the horse. The goal of this CE is to provide training directly related to their mission.”
Dr. Dionne Benson, RMTC

“Consistency of protocols across North American racing is critical to protect the welfare of the traveling horse. It is therefore crucial that every track and regulatory authority ensure their veterinarians participate in this one-of-a-kind event.”

Steve Koch, NTRA Safety & Integrity Alliance

#RegVetCE Registration


RegVetCE19 registration is now closed. 

Contact Julia Sisoumankhara for additional information. or (859) 759-4081

Hotel Accomodations


18.25 CE credits approved by AAVSB RACE program

The agenda was developed by the RMTC and the NTRA Safety & Integrity Alliance in collaboration with a committee of Equine Medical Directors and racetrack veterinarians.

Monday, March 4, 2019

Time Subject Speaker
8:00-8:15 a.m. Welcome to Gulfstream
8:15-noon (9:45-10:00 BREAK) Pharmacology Review for Regulatory Veterinarians Dr. Cynthia Cole (U. of Florida)
Noon-1:00 p.m.

1:00-4:00 p.m.


Pre-Race Examinations in the Shed Row

4:00-4:15 p.m.

4:15-5:15 p.m.


Discussion of Shed Row Examination Findings

Dr. Barrie Grant

Tuesday, March 5, 2019

Time Subject Speaker
8:00-9:00 a.m. Medication Control: Out of Competition Testing Strategies Internationally and Within the U.S. Dr. Rick Arthur (California Horse Racing Board)

Dr. Tessa Muir (British Horseracing Authority)

Izzy Trejo (New Mexico Racing Commission)

9:00-9:30 a.m. What are we doing here and why am I in this handbasket? – Why we regulate therapeutic medication in horseracing. Dr. Mary Scollay (Kentucky Horse Racing Commission)
9:30-9:45 a.m.

9:45-10:45 a.m.


What should we be asking from our laboratories?  Turn around time, unknowns, and beyond.

Anthony Fontana Ph.D.  (Truesdail Labs)

Petra Hartman (Industrial Labs)

Dr. Lynn Hovda (Minnesota Racing Commission)

10:45-11:45 a.m. The statistics of threshold development – focusing on the 95/95 Threshold Interval. Ashley Hill Ph.D. (U.C. Davis)
11:45-12:15 p.m.

12:15-1:15 p.m.

1:15-3:45 p.m.

Environmental Contamination


The great unknown: compounding, illegal new medications, misbranding, mislabeling, and adulterated substances

Dr. Mary Scollay (KHRC)

Dr. Kenton Morgan (Zoetis)

3:45-4:00 p.m.

4:00-5:00 p.m.


Understanding the global discussion – a comparison of international and US medication regulation

Dr. Dionne Benson (RMTC)

Dr. Tessa Muir (BHA)

Alex Waldrop (NTRA, RMTC)